Roivant Sciences Ownership | Who Owns Roivant Sciences?
Roivant Sciences Ownership Summary
Roivant Sciences is owned by 80.51% institutional investors, 21.45% insiders. Fmr is the largest institutional shareholder, holding 11.68% of ROIV shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 4.14% of its assets in Roivant Sciences shares.
ROIV Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Roivant Sciences | 80.51% | 21.45% | -1.96% |
| Sector | Healthcare Stocks | 244.59% | 12.11% | -156.70% |
| Industry | Biotech Stocks | 379.61% | 11.70% | -291.31% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 81.02M | 11.68% | $2.87B |
| Blackrock funding, inc. /de | 48.24M | 6.95% | $1.71B |
| Vanguard group | 42.06M | 6.18% | $912.68M |
| Morgan stanley | 42.59M | 6.14% | $1.51B |
| Blackrock | 35.37M | 4.41% | $373.86M |
| Qvt financial lp | 23.72M | 3.42% | $839.56M |
| Vanguard capital management | 22.12M | 3.19% | $782.94M |
| Goldman sachs group | 18.56M | 2.67% | $656.71M |
| State street | 17.80M | 2.56% | $629.80M |
| Ubs group | 17.47M | 2.52% | $618.14M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Qvt financial lp | 23.72M | 49.36% | $839.56M |
| Patient square capital lp | 8.02M | 43.97% | $283.86M |
| Atalaya capital management lp | 1.71M | 40.31% | $18.13M |
| Davern capital partners, lp | 1.93M | 11.66% | $68.41M |
| Whitefort capital management, lp | 1.02M | 8.89% | $36.06M |
| Darwin global management | 6.75M | 6.23% | $234.33M |
| Affinity asset advisors | 3.75M | 6.00% | $132.71M |
| Blackbarn capital partners lp | 2.00M | 5.97% | $70.78M |
| Two seas capital lp | 8.48M | 5.94% | $299.94M |
| Cutter capital management, lp | 1.30M | 5.71% | $13.12M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Goldman sachs group | 18.56M | 0.06% | 7.44M |
| Norges bank | 4.75M | 0.02% | 4.75M |
| Farallon capital management | 14.31M | 2.34% | 4.63M |
| Blackrock funding, inc. /de | 48.24M | 0.03% | 3.98M |
| Sixth street partners management company | 3.72M | 0.02% | 3.72M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Morgan stanley | 42.59M | 0.08% | -9.24M |
| Ubs group | 17.47M | 0.08% | -5.15M |
| Anchorage capital group | - | - | -4.83M |
| Avoro capital advisors | - | - | -4.65M |
| Toms capital investment management lp | - | - | -4.09M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 4.75M | 0.02% | 4.75M | $168.01M |
| Sixth street partners management company | 3.72M | 0.02% | 3.72M | $131.49M |
| Nearwater capital markets | 1.50M | 0.92% | 1.50M | $53.09M |
| Cutter capital management, lp | 1.30M | 5.71% | 1.30M | $13.12M |
| Cubist systematic strategies | 943.16K | 0.07% | 943.16K | $14.27M |
Sold Out
| Holder | Change |
|---|---|
| Optiver b.v. | -2.00 |
| Stephens consulting | -3.00 |
| Curio wealth | -11.00 |
| Mather group, llc. | -13.00 |
| Cornerstone planning group | -27.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 513 | 10.80% | 558,639,782 | 5.37% | 80 | 1.41% | 299 | 13.26% | 139 | 9.45% |
| Mar 31, 2026 | 240 | -42.72% | 123,029,474 | -75.82% | 17 | 0.33% | 131 | -49.42% | 64 | -33.33% |
| Dec 31, 2025 | 302 | -16.80% | 336,769,510 | -32.86% | 49 | 0.91% | 194 | 1.04% | 60 | -37.50% |
| Sep 30, 2025 | 297 | -14.41% | 349,519,827 | -24.94% | 51 | 1.19% | 157 | -11.80% | 81 | -23.58% |
| Jun 30, 2025 | 351 | 8.67% | 514,292,667 | -7.04% | 72 | 1.24% | 180 | 19.21% | 107 | 0.94% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl S | 29.93M | 4.14% | 229.90K |
| Fidelity Growth Company Fund | 22.63M | 3.13% | 103.96K |
| Fidelity Growth Compy Commingled Pl O | 21.15M | 2.86% | 439.20K |
| Vanguard Morn Total Stk Mkt Idx Investor | 15.99M | 2.22% | 1.18M |
| Vanguard Total Stock Mkt Idx Inv | 15.99M | 2.22% | 1.18M |
| Vanguard MStar Total Stk Mkt Idx Invest | 16.04M | 2.22% | 48.14K |
| iShares Core S&P Mid-Cap ETF | 15.49M | 2.14% | 476.00 |
| Vanguard US Total Market Shares ETF | 14.26M | 2.00% | 14.26M |
| Vanguard Small Cap Index | 11.57M | 1.60% | 26.43K |
| SPDR® S&P Biotech ETF | 7.21M | 1.06% | 16.07K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 08, 2026 | Fitzgerald Meghan | - | Sell | $798.00K |
| Aug 28, 2026 | Venker Eric | President & Immunovant CEO | Sell | $5.92M |
| Aug 28, 2026 | Venker Eric | President & Immunovant CEO | Sell | $1.23M |
| Aug 20, 2026 | Sukhatme Mayukh | President & CIO | Sell | $653.46K |
| Aug 19, 2026 | Sukhatme Mayukh | President & CIO | Sell | $6.43M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | - | 11 |
| 2026 Q2 | - | 27 |
| 2026 Q1 | - | 24 |
| 2025 Q4 | - | 53 |
| 2025 Q3 | 1 | 9 |
ROIV Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools